EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Apalutamide‑induced prostate‑specific antigen response and its association with clinical outcomes in metastatic castration sensitive prostate cancer (Review)

Srivatsa N, Chandrakanth Mv, Avinash Upadhyay, Pankaj Sonone, Shruti Dharmadhikari, Gaurav Puppalwar, Chintan Khandhedia, Amey Mane, Suyog Mehta

Molecular and Clinical Oncology · 20.07.2026 · 25 (3) · 1-8

DOI: 10.3892/mco.2026.2964 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Molecular and Clinical Oncology, online erschienen am 20.07.2026. Verfasst von Srivatsa N und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Uro-Oncology, Sri Shankara Cancer Hospital and Research Centre, Sri Shankara Cancer Foundation, Affiliated to Rajiv Gandhi University o…. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

apalutamidecastration-sensitive prostate cancerdeep prostate-specific antigen suppressionprognostic biomarkersprostate-specific antigen response

Autor:innen und Institutionen

  • Department of Uro-Oncology, Sri Shankara Cancer Hospital and Research Centre, Sri Shankara Cancer Foundation, Affiliated to Rajiv Gandhi University of Health Sciences, Bengaluru, Karnataka 560070, India.
  • Department of Medical Oncology and Hemato-Oncology, Narayana Super Speciality Hospital and Cancer Institute, Affiliated to West Bengal University of Health Sciences, Howrah, West Bengal 711103, India.
  • Consultant, Department of Medical Oncology, BIG Apollo Spectra Hospitals, Patna, Bihar 800007, India.
  • Sun Pharma Laboratories Limited, Mumbai, Maharashtra 400063, India.

Zitieren

APA

N, S., Mv, C., Upadhyay, A., Sonone, P., Dharmadhikari, S., Puppalwar, G., Khandhedia, C., Mane, A., & Mehta, S. (2026). Apalutamide‑induced prostate‑specific antigen response and its association with clinical outcomes in metastatic castration sensitive prostate cancer (Review). Molecular and Clinical Oncology, 25(3), 1-8. https://doi.org/10.3892/mco.2026.2964

Vancouver

N S, Mv C, Upadhyay A, Sonone P, Dharmadhikari S, Puppalwar G, et al. Apalutamide‑induced prostate‑specific antigen response and its association with clinical outcomes in metastatic castration sensitive prostate cancer (Review). Molecular and Clinical Oncology. 2026;25(3):1-8. doi:10.3892/mco.2026.2964

BibTeX
@article{N2026,
  author = {N, Srivatsa and Mv, Chandrakanth and Upadhyay, Avinash and Sonone, Pankaj and Dharmadhikari, Shruti and Puppalwar, Gaurav and Khandhedia, Chintan and Mane, Amey and Mehta, Suyog},
  title = {Apalutamide‑induced prostate‑specific antigen response and its association with clinical outcomes in metastatic castration sensitive prostate cancer (Review)},
  journal = {Molecular and Clinical Oncology},
  year = {2026},
  volume = {25},
  number = {3},
  pages = {1--8},
  doi = {10.3892/mco.2026.2964}
}
Kostenlos starten →